SK hynix Announces 1Q25 Financial Results
Revenues at 17.6391 trillion won, operating profit at 7.4405 trillion won, net profit at 8.1082 trillion won Both revenues, operating profit achieve 2nd highest quarterly records and operating margin improves for 8th consecutive quarters Company...
STAK Inc. Announces First Half of Fiscal Year 2025 Financial Results
CHANGZHOU, China, April 24, 2025 /PRNewswire/ -- STAK Inc. (the "Company" or "STAK") (Nasdaq: STAK), a fast-growing company specializing in the research, development, manufacturing, and sale of oilfield-specialized production and maintenance...
From D1 Athletics to Historic Theaters accesso® Welcomes New Live Entertainment Clients
ORLANDO, Fla., April 23, 2025 /PRNewswire/ -- accesso Technology Group (AIM: ACSO), the premier technology solutions provider to leisure, entertainment and cultural markets, is proud to announce the addition of several venues to the accesso...
New Oriental Announces Results for the Third Fiscal Quarter Ended February 28, 2025
BEIJING, April 23, 2025 /PRNewswire/ -- New Oriental Education & Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU/ 9901.SEHK), a provider of private educational services in China, today announced its unaudited financial results...
Doer Biologics Announces First Patient Dosed in Phase 2 Study of DR10624 for Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
HANGZHOU, China, April 22, 2025 /PRNewswire/ -- Zhejiang Doer Biologics Co., Ltd. ("Doer Bio"), a clinical stage biopharmaceutical company developing innovative biotherapeutics for metabolic diseases and cancers, today announces that DR10624, its...
Ascletis Announces Positive Topline Results of U.S. Phase Ib Multiple Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Submission of 13-week Phase IIa Study Protocol to FDA
- ASC30 oral once-daily tablet demonstrated a 6.5% placebo-adjusted mean body weight reduction from baseline after four-week treatment using weekly doses with titrations of 2 mg, 10 mg, 20 mg , and 40 mg doses. - ASC30 oral once-daily tablet also...
Cheche Group Announces Partnership with Jetour Auto
BEIJING, April 22, 2025 /PRNewswire/ -- Cheche Group Inc. (NASDAQ: CCG) ("Cheche" or the "Company"), China's leading auto insurance technology platform, today announced that it has entered into a partnership with Wuhu Jetour Automobile Sales Company...
ENGWE Announces Global Pricing Adjustment Amid Tariff Challenges, Strengthens Long-Term Brand Strategy
NEW YORK, April 22, 2025 /PRNewswire/ -- ENGWE, a leading brand in the electric bike field, has announced a strategic adjustment to its omnichannel pricing structure, effective May 2025. This change will apply across the entire product line in...
DXC Announces AI Workbench; Ferrovial to Serve as Anchor Client
DXC's AI Workbench combines industry and AI expertise to scale outcomes for global customers ASHBURN, Va., April 22, 2025 /PRNewswire/ -- DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, introduced today DXC AI...
Onward Therapeutics Announces IMPD Approval for Its Subsidiary Emercell to Start Clinical Investigation of Allogeneic NK Cell Therapy OT-C001 in Combination with Rituximab
EPALINGES, Switzerland and PARIS, April 22, 2025 /PRNewswire/ -- Onward Therapeutics SA, a biotechnology company dedicated to advancing innovative cancer immunotherapies, announced that its subsidiary, Emercell SAS, has received Investigational...